Parliamentary Question – CETA & Market Access for Pharma Sector

Market Access and Intellectual Property Rights are high on the agenda of the European Commission in the last stages of the negotiations for the Comprehensive Economic and Trade Agreement (CETA) currently ongoing between the EU and Canada, according to an answer by the Commission to a parliamentary question tabled by Silvana Koch-Mehrin. In her question she pointed at the significant gap in market access for the European pharmaceutical industry on the Canadian market.

Parliamentary Question: EU‑Canada negotiations for a Comprehensive Economic and Trade Agreement: levelling the playing field for the life science industry.